0.39

6.25% -0.89

Seelos Therapeutics Inc (SEEL)

Overview News Price History Option Chain Financials Why SEEL Down? Discussions Forecast Stock Split

Seelos Therapeutics Inc stock is traded at $0.39, with a volume of 55,059. It is down -6.25% in the last 24 hours and down -62.57% over the past month.

Previous Close:

$1.28

Open:

$0.498

24h Volume:

55,059

Relative Volume:

66.00

Market Cap:

$N/A

Revenue:

Net Income/Loss:

$-37.07M

P/E Ratio:

-0.5652

EPS:

-0.69

Net Cash Flow:

$-23.91M

1W Performance:

-6.25%

1M Performance:

-62.57%

6M Performance:

-97.12%

1Y Performance:

-95.25%

1-Day Range:

$0.37

$0.498

1-Week Range:

$0.37

$0.498

52-Week Range:

$0.37

$0.498

Seelos Therapeutics Inc Stock (SEEL) Company Profile

Name

Seelos Therapeutics Inc

Sector

Healthcare (1205)

Industry

Biotechnology (682)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

SEEL's Discussions on Twitter

Compare SEEL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SEEL	0.39	0	0	-37.07M	-23.91M	-0.69
VRTX	467.12	119.83B	10.63B	-479.80M	-1.35B	13.33
REGN	762.38	83.28B	13.85B	4.65B	3.32B	35.06
ARGX	567.35	33.74B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.38B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.83	24.08B	3.30B	-501.07M	1.03B	11.54

Seelos Therapeutics Inc Stock (SEEL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-27-21	Upgrade	ROTH Capital	Neutral → Buy
Jul-01-21	Initiated	Guggenheim	Buy
Jun-01-21	Initiated	Cantor Fitzgerald	Overweight
May-17-21	Downgrade	ROTH Capital	Buy → Neutral
Mar-30-21	Initiated	B. Riley Securities	Buy
Nov-14-19	Initiated	The Benchmark Company	Speculative Buy
May-14-19	Initiated	ROTH Capital	Buy

View All

Seelos Therapeutics Inc Stock (SEEL) Latest News

Nov 15, 2024

Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock - Quantisnow

Nov 15, 2024

Nov 01, 2024

Seelos Therapeutics Announces 1-for-16 Reverse Stock Split - GuruFocus.com

Nov 01, 2024

Oct 31, 2024

Seelos Announces Postponement of its Annual Meeting of Stockholders - GuruFocus.com

Oct 31, 2024

Oct 30, 2024

SEELOS THERAPEUTICS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Oct 30, 2024

Oct 29, 2024

Seelos Therapeutics announces the signing of a Material Transfer - GuruFocus.com

Oct 29, 2024

Oct 24, 2024

Seelos Announces Second Postponement of its Annual Meeting of Stockholders - StockTitan

Oct 24, 2024

Oct 20, 2024

Seelos Therapeutics (NASDAQ:SEEL) and Zoetis (NYSE:ZTS) Head-To-Head Contrast - Defense World

Oct 20, 2024

Oct 16, 2024

SEEL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Oct 16, 2024

Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 1.28, Reflecting a -47.76 Downturn - The Dwinnex

Oct 16, 2024

Oct 15, 2024

Seelos Therapeutics Delisted From Nasdaq, Will Transition To OTC Market - Benzinga

Oct 15, 2024

Seelos gets Nasdaq delisting notice - MSN

Oct 15, 2024

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - Morningstar

Oct 15, 2024

Oct 14, 2024

SEEL stock touches 52-week low at $2.37 amid market challenges By Investing.com - Investing.com South Africa

Oct 14, 2024

SEEL stock touches 52-week low at $2.37 amid market challenges - Investing.com

Oct 14, 2024

Oct 07, 2024